Overview

Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Status:
Recruiting

Trial end date:
2028-12-01

Target enrollment:
0

Participant gender:
All

Summary

Norfloxacin versus Norfloxacin with Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Phase:

Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Tanta University

Treatments:

Norfloxacin

Criteria

Inclusion Criteria:

- cirrhotic patients with ascites who had previous episodes of SBP.

Exclusion Criteria:

- 1. Allergy or contraindication for the used drugs. 2. Recent antibiotics therapy in
the previous 2 weeks. 3. Patients with hepatocellular carcinoma or other neoplasia. 4.
Pregnant and lactating women.